803 related articles for article (PubMed ID: 18465373)
1. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
[TBL] [Abstract][Full Text] [Related]
2. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.
Rosenberg DR; Mirza Y; Russell A; Tang J; Smith JM; Banerjee SP; Bhandari R; Rose M; Ivey J; Boyd C; Moore GJ
J Am Acad Child Adolesc Psychiatry; 2004 Sep; 43(9):1146-53. PubMed ID: 15322418
[TBL] [Abstract][Full Text] [Related]
3. Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder.
Yücel M; Harrison BJ; Wood SJ; Fornito A; Wellard RM; Pujol J; Clarke K; Phillips ML; Kyrios M; Velakoulis D; Pantelis C
Arch Gen Psychiatry; 2007 Aug; 64(8):946-55. PubMed ID: 17679639
[TBL] [Abstract][Full Text] [Related]
4. 1H-MRS of the anterior cingulate cortex in childhood and adolescent obsessive-compulsive disorder: a case-control study.
Ortiz AE; Ortiz AG; Falcon C; Morer A; Plana MT; Bargalló N; Lázaro L
Eur Neuropsychopharmacol; 2015 Jan; 25(1):60-8. PubMed ID: 25499604
[TBL] [Abstract][Full Text] [Related]
5. Brain magnetic resonance spectroscopy in obsessive-compulsive disorder: the importance of considering subclinical symptoms of anxiety and depression.
Bédard MJ; Chantal S
Psychiatry Res; 2011 Apr; 192(1):45-54. PubMed ID: 21377338
[TBL] [Abstract][Full Text] [Related]
6. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
[TBL] [Abstract][Full Text] [Related]
7. Brain neurochemistry in unmedicated obsessive-compulsive disorder patients and effects of 12-week escitalopram treatment:
Parmar A; Sharan P; Khandelwal SK; Agarwal K; Sharma U; Jagannathan NR
Psychiatry Clin Neurosci; 2019 Jul; 73(7):386-393. PubMed ID: 30973183
[TBL] [Abstract][Full Text] [Related]
8. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety.
Whiteside SP; Port JD; Deacon BJ; Abramowitz JS
Psychiatry Res; 2006 Mar; 146(2):137-47. PubMed ID: 16507346
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy.
Chang Y; Woo ST; Lee JJ; Song HJ; Lee HJ; Yoo DS; Kim SH; Lee H; Kwon YJ; Ahn HJ; Ahn JH; Park SJ; Weon YC; Chung IS; Jeong KS; Kim Y
Neurotoxicology; 2009 Nov; 30(6):950-7. PubMed ID: 19631686
[TBL] [Abstract][Full Text] [Related]
10. Neurochemistry of the hippocampus in patients with obsessive-compulsive disorder.
Atmaca M; Yildirim H; Ozdemir H; Koc M; Ozler S; Tezcan E
Psychiatry Clin Neurosci; 2009 Aug; 63(4):486-90. PubMed ID: 19531109
[TBL] [Abstract][Full Text] [Related]
11. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study.
Szeszko PR; Ardekani BA; Ashtari M; Malhotra AK; Robinson DG; Bilder RM; Lim KO
Arch Gen Psychiatry; 2005 Jul; 62(7):782-90. PubMed ID: 15997020
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for reduced neuronal integrity in the anterior cingulate.
Tükel R; Aydın K; Ertekin E; Özyıldırım SŞ; Taravari V
Psychiatry Res; 2014 Dec; 224(3):275-80. PubMed ID: 25241042
[TBL] [Abstract][Full Text] [Related]
13. Decreased caudate N-acetyl-l-aspartic acid in pediatric obsessive-compulsive disorder and the effects of behavior therapy.
Whiteside SP; Abramowitz JS; Port JD
Psychiatry Res; 2012 Apr; 202(1):53-9. PubMed ID: 22704757
[TBL] [Abstract][Full Text] [Related]
14. A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.
Starck G; Ljungberg M; Nilsson M; Jönsson L; Lundberg S; Ivarsson T; Ribbelin S; Ekholm S; Carlsson A; Forssell-Aronsson E; Carlsson ML
J Neural Transm (Vienna); 2008 Jul; 115(7):1051-62. PubMed ID: 18528631
[TBL] [Abstract][Full Text] [Related]
15. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
16. Spectroscopic abnormalities in the pregenual anterior cingulate cortex in obsessive-compulsive disorder using proton magnetic resonance spectroscopy: a controlled study.
Kosová E; Pajuelo D; Fajnerová I; Greguš D; Brunovský M; Stopková P; Škoch A; Fürstová P; Španiel F; Horáček J
BMC Psychiatry; 2023 Oct; 23(1):734. PubMed ID: 37817131
[TBL] [Abstract][Full Text] [Related]
17. Cortical neurochemistry in euthymic patients with bipolar I disorder.
Scherk H; Backens M; Schneider-Axmann T; Usher J; Kemmer C; Reith W; Falkai P; Gruber O
World J Biol Psychiatry; 2009; 10(4):285-94. PubMed ID: 19921970
[TBL] [Abstract][Full Text] [Related]
18. Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder.
Russell A; Cortese B; Lorch E; Ivey J; Banerjee SP; Moore GJ; Rosenberg DR
J Child Adolesc Psychopharmacol; 2003; 13 Suppl 1():S31-8. PubMed ID: 12880498
[TBL] [Abstract][Full Text] [Related]
19. Effects of intensive cognitive-behavioral therapy on cingulate neurochemistry in obsessive-compulsive disorder.
O'Neill J; Gorbis E; Feusner JD; Yip JC; Chang S; Maidment KM; Levitt JG; Salamon N; Ringman JM; Saxena S
J Psychiatr Res; 2013 Apr; 47(4):494-504. PubMed ID: 23290560
[TBL] [Abstract][Full Text] [Related]
20. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis.
Yildiz-Yesiloglu A; Ankerst DP
Psychiatry Res; 2006 Jun; 147(1):1-25. PubMed ID: 16806850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
